Beryl Drugs Limited (BOM:524606)
24.95
+0.36 (1.46%)
At close: Sep 7, 2026
Beryl Drugs Market Cap
Beryl Drugs has a market cap or net worth of 124.71 million as of September 4, 2026. Its market cap has increased by 2.20% in one year.
Market Cap
124.71M
Enterprise Value
146.39M
Revenue
213.23M
Ranking
n/a
PE Ratio
19.97
Stock Price
24.95
ChartMarket Cap Chart
Since June 14, 2005, Beryl Drugs's market cap has increased from 3.69M to 124.71M, an increase of 3,275.81%. That is a compound annual growth rate of 18.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 124.71M | 5.09% |
| Dec 31, 2025 | 118.68M | -35.27% |
| Dec 31, 2024 | 183.34M | 63.50% |
| Dec 29, 2023 | 112.14M | 70.08% |
| Dec 30, 2022 | 65.93M | 7.26% |
| Dec 31, 2021 | 61.47M | 54.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Colinz Laboratories | 180.12M |
| Zenith Healthcare | 170.89M |
| Add-Shop E-Retail | 168.18M |
| Desh Rakshak Aushdhalaya | 153.28M |
| Shamrock Industrial Company | 140.84M |
| Norris Medicines | 136.51M |
| Unjha Formulations | 130.79M |
| Ortin Global | 123.52M |